Description

Singlon (montelukast) Chewable Tablets 4 mg. №28

Ingredients

Active ingredient: Montelukast Sodium 4 mg.
Other ingredients: Mannitol, microcrystalline cellulose, croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, aspartame, cherry flavor.

Dosage

Recommended dosage: 1 tablet daily, or as directed by a healthcare professional. Chew the tablet before swallowing.

Indications

Singlon Chewable Tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients aged 2 years and older.

Contraindications

Do not use Singlon Chewable Tablets if you are allergic to montelukast or any other ingredients in the product. Consult a healthcare provider before use if you have phenylketonuria or liver disease.

Directions

For best results, take Singlon Chewable Tablets regularly at the same time each day. Follow the dosage instructions provided by your doctor or pharmacist.

Scientific Evidence

Montelukast, the active ingredient in Singlon Chewable Tablets, is a leukotriene receptor antagonist that works by blocking the action of leukotrienes in the body. Leukotrienes are chemicals in the body that can cause asthma symptoms by constricting airways, increasing mucus production, and inflammation. Clinical studies have shown that montelukast is effective in improving asthma symptoms, reducing the frequency of asthma attacks, and improving lung function.

Additional Information

It is important to note that Singlon Chewable Tablets are not meant for the treatment of acute asthma attacks. If an acute attack occurs, use a rescue inhaler as directed by your healthcare provider. Regular monitoring and follow-up with a healthcare professional are essential to ensure the optimal management of asthma symptoms.

Pharmacological Effects

Montelukast exerts its pharmacological effects by selectively antagonizing leukotriene receptors in the airways, thereby inhibiting the bronchoconstriction, mucus secretion, and inflammation associated with asthma. By blocking the action of leukotrienes, montelukast helps to improve airflow, reduce asthma symptoms, and prevent asthma attacks.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the efficacy of montelukast in the management of asthma, both in adults and children. Compared to other asthma medications, montelukast has shown comparable effectiveness in controlling asthma symptoms and improving lung function. Additionally, montelukast is well-tolerated with a low incidence of adverse effects, making it a favorable option for long-term asthma management.

Overall, Singlon Chewable Tablets containing montelukast offer a reliable and effective treatment option for individuals with asthma, backed by scientific evidence and clinical trials supporting its efficacy and safety.